Authors:
PARMEE ER
OK HO
CANDELORE MR
TOTA L
DENG LP
STRADER CD
WYVRATT MJ
FISHER MH
WEBER AE
Citation: Er. Parmee et al., DISCOVERY OF L-755,507 - A SUBNANOMOLAR HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST, Bioorganic & medicinal chemistry letters, 8(9), 1998, pp. 1107-1112
Authors:
NAYLOR EM
COLANDREA VJ
CANDELORE MR
CASCIERI MA
COLWELL LF
DENG LP
FEENEY WP
FORREST MJ
HOM GJ
MACINTYRE DE
STRADER CD
TOTA L
WANG PR
WYVRATT MJ
FISHER MH
WEBER AE
Citation: Em. Naylor et al., 3-PYRIDYLETHANOLAMINES - POTENT AND SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONISTS, Bioorganic & medicinal chemistry letters, 8(21), 1998, pp. 3087-3092
Authors:
WEBER AE
OK HO
ALVARO RF
CANDELORE MR
CASCIERI MA
CHIU SHL
DENG LP
FORREST MJ
HOM GJ
HUTCHINS JE
KAO J
MACINTYRE DE
MATHVINK RJ
MCLOUGHLIN D
MILLER RR
NEWBOLD RC
OLAH TV
PARMEE ER
PERKINS L
STEARNS RA
STRADER CD
SZUMILOSKI J
TANG YS
TOTA L
VICARIO PP
WYVRATT MJ
FISHER MH
Citation: Ae. Weber et al., 3-PYRIDYLOXYPROPANOLAMINE AGONISTS OF THE BETA(3) ADRENERGIC-RECEPTORWITH IMPROVED PHARMACOKINETIC PROPERTIES, Bioorganic & medicinal chemistry letters, 8(16), 1998, pp. 2111-2116
Authors:
FISHER MH
AMEND AM
BACH TJ
BARKER JM
BRADY EJ
CANDELORE MR
CARROLL D
CASCIERI MA
CHIU SHL
DENG LP
FORREST MJ
HEGARTYFRISCINO B
GUAN XM
HOM GJ
HUTCHINS JE
KELLY LJ
MATHVINK RJ
METZGER JM
MILLER RR
OK HO
PARMEE ER
SAPERSTEIN R
STRADER CD
STEARNS RA
THOMPSON GM
TOTA L
VICARIO PP
WEBER AE
WOODS JW
WYVRATT MJ
ZAFIAN PT
MACINTYRE DE
Citation: Mh. Fisher et al., A SELECTIVE HUMAN BETA(3) ADRENERGIC-RECEPTOR AGONIST INCREASES METABOLIC-RATE IN RHESUS-MONKEYS, The Journal of clinical investigation, 101(11), 1998, pp. 2387-2393
Citation: Lp. Deng, UNDERSTANDING JAPANESE DIRECT-INVESTMENT IN CHINA (1985-1993) - AN INTERCULTURAL ANALYSIS, The American journal of economics and sociology, 56(1), 1997, pp. 115-127
Authors:
CANDELORE MR
DENG LP
TOTA LM
KELLY LJ
CASCIERI MA
STRADER CD
Citation: Mr. Candelore et al., PHARMACOLOGICAL CHARACTERIZATION OF A RECENTLY DESCRIBED HUMAN BETA-3-ADRENERGIC RECEPTOR MUTANT, Endocrinology, 137(6), 1996, pp. 2638-2641
Citation: Sk. Wang et al., DEFECTIVE BINDING OF NEUTRAL LIPIDS BY A CARBOXYL-TERMINAL DELETION MUTANT OF CHOLESTERYL ESTER TRANSFER PROTEIN - EVIDENCE FOR A CARBOXYL-TERMINAL CHOLESTERYL ESTER BINDING-SITE ESSENTIAL FOR NEUTRAL LIPID TRANSFER ACTIVITY, The Journal of biological chemistry, 270(2), 1995, pp. 612-618
Citation: Lp. Deng et al., PLASMA-LEVELS OF VON-WILLEBRAND-FACTOR AND FIBRONECTIN AS MARKERS OF PERSISTING ENDOTHELIAL DAMAGE IN PREECLAMPSIA, Obstetrics and gynecology, 84(6), 1994, pp. 941-945
Citation: Sc. Stevenson et al., HUMAN PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN CONSISTS OF A MIXTUREOF 2 FORMS REFLECTING VARIABLE GLYCOSYLATION AT ASPARAGINE-341, Biochemistry, 32(19), 1993, pp. 5121-5126